New Zealand

 

Wafer-thin health care service profits at Bupa

Why did Bupa, the international health insurer which is also one of the largest health care service players outside of the USA, announce its 2018 results so quietly that HBI isn't aware of any UK daily reporting them this year? The figures show that Bupa's £3.37bn of revenue from nursing homes, hospitals, dentistry and primary care across a dozen countries, barely made money. Could this be down to its interesting governance structure?
April 23, 2019

UK nursing home real-estate proving attractive to investors

According to a report by real-estate investor Octopus Healthcare, both current and new investors in UK elderly care will be allocating increasing resources to the sector, despite the market experiencing significant financial challenges. We speak to the company's CEO, Benjamin Davis, about why UK elderly care remains a hotspot for investment.
December 6, 2018

Luye Medical preparing for $500m IPO

Singapore-based healthcare services provider Luye Medical Group is preparing an initial public offering that could raise around $500m.
March 22, 2018

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.
January 31, 2018

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.
January 29, 2018

Interview: Charles Wang, Group CEO, Luye Medical Group

Formed as recently as 2015, Singapore-based Luye Medical Group has become one of the major contenders in health care services across China, Australia and SE Asia. It is part of the Luye Life Sciences Group which owns Luye Pharma Group, one of the largest pharmaceutical companies in China and separately listed on the Hong Kong Stock Exchange. Luye Medical Group acquired Healthe Care, the third largest Australian for-profit hospital operators in 2016. It has since expanded its business rapidly adding healthcare operations such as oncology (Singapore), inpatient, outpatient and community based health care services (Australia) and rehabilitation and maternity hospitals (China). The aim, says Wang, is mainly to provide a value-based healthcare experience to meet the needs of the middle class and patients with private insurance coverage across SE Asia, Australia and China. Here we talk to him about Luye Medical Group’s plans and how it views the Chinese market. Wang is a speaker at HBI 2018, the global health care service event in London from April 10 to 11.
January 25, 2018

Laureate sells off private universities in Europe

Laureate Education Inc, the NASDAQ listed private university chain, has agreed to sell for-profit European University Cyprus (EUC), which has a medical school and the only accredited dentistry program in Cyprus. We hear other European assets may follow.
November 22, 2017

Can you build a business on educating doctors and nurses?

Can you make a successful business educating doctors and nurses? You can if the growth of the world’s largest higher education network, Laureate, is anything to go by. Healthcare Nova catches up with Dr. Francisco Gutierrez, senior vice president of medicine and health sciences.
August 25, 2017

Overall revenues up at Bupa – but Bupa Global’s profits decline

Overall revenues at Bupa are up according to its half year results – with only Bupa Global notably blotting the copybook with a decline in profits. Here is what Bupa had to say to Healthcare Europa and Nova about those Bupa Global figures - and their views on the thinking behind the recent sale of Bupa Home Healthcare to Celesio in the UK - together with a summary of the half-year report.
August 17, 2016

So what really happened at Bupa?

After four years, in which he transformed Bupa with a £1.8bn M&A drive, the company announced that CEO Stuart Fletcher is to leave after failing to meet expectations. His departure follows 2015 results which saw a fall of pre-tax profits of 39% to £347m. Where does that leave his plans to build an international brand with strengths in services as well as insurance? What really went wrong? With 2015 sales of £9.8bn, Bupa still has heft. Outside the USA, it remains one of the two largest international private medical insurers, the largest international dentistry player, one of the largest care home groups and, probably, the largest player in outpatient care – certainly the only one with scale in four continents.
March 30, 2016
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us